These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21083794)

  • 1. Natural language processing for the development of a clinical registry: a validation study in intraductal papillary mucinous neoplasms.
    Al-Haddad MA; Friedlin J; Kesterson J; Waters JA; Aguilar-Saavedra JR; Schmidt CM
    HPB (Oxford); 2010 Dec; 12(10):688-95. PubMed ID: 21083794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic lesions and intraductal neoplasms of the pancreas.
    Fasanella KE; McGrath K
    Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
    Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
    World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study.
    Kobayashi G; Fujita N; Maguchi H; Tanno S; Mizuno N; Hanada K; Hatori T; Sadakari Y; Yamaguchi T; Tobita K; Doi R; Yanagisawa A; Tanaka M;
    Pancreas; 2014 May; 43(4):532-8. PubMed ID: 24717801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms.
    Rosenblatt R; Dorfman V; Epelboym I; Poneros JM; Sethi A; Lightdale C; Woo Y; Gress FG; Allendorf JD; Schrope BA; Chabot JA; Gonda TA
    Pancreas; 2015 Apr; 44(3):478-83. PubMed ID: 25411806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".
    Matthaei H; Wu J; Dal Molin M; Shi C; Perner S; Kristiansen G; Lingohr P; Kalff JC; Wolfgang CL; Kinzler KW; Vogelstein B; Maitra A; Hruban RH
    Am J Surg Pathol; 2014 Mar; 38(3):360-3. PubMed ID: 24525507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
    Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
    Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
    Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms.
    Frankel TL; LaFemina J; Bamboat ZM; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Allen PJ
    HPB (Oxford); 2013 Oct; 15(10):814-21. PubMed ID: 23782351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pancreatic cystic neoplasms revisited. Part III. Intraductal papillary mucinous neoplasms.
    Sakorafas GH; Smyrniotis V; Reid-Lombardo KM; Sarr MG
    Surg Oncol; 2011 Jun; 20(2):e109-18. PubMed ID: 21396811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.